Search
for
Sort by
Research 181–210 of 493
- Oxidative stress and alopecia areata
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- A Comprehensive Systematic Review of the Association Between Vitamin D Deficiency and Alopecia Areata
- Alopecia Areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Alopecia Areata
- An Overview of Alopecias
- Alopecia areata universalis nach Sitagliptin-Einnahme
- Modern Management Approaches for Alopecia Areata
- Alopecia Areata: Current Review
- Special Stains and Immunohistochemical Stains in Hair Pathology
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- New treatment modalities of alopecia areata
- Immunoglobulin E and Serum Interleukin-13 and Bacteria in Patients with Alopecia Areata
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Recommendations on trichological treatments during COVID-19 pandemic
- Differential impact of environmental factors on systemic and localized autoimmunity
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy
- Novel therapies for alopecia areata: The era of rational drug development
- Lipid nanocarriers as innovative strategies for hair regrowth